XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Expenses:        
Research and development $ 816,697 $ 91,911 $ 2,042,890 $ 291,655
General and administrative 1,480,356 401,636 4,057,046 1,341,271
Total operating expenses 2,297,053 493,547 6,099,936 1,632,926
Loss from operations (2,297,053) (493,547) (6,099,936) (1,632,926)
Other Income (Expenses):        
Interest income 10,212 23 33,627 138
Gain (loss) on change in fair value of derivative liability 9,885 (53,257)
Interest expense (1,193) (107,382) (3,557) (217,821)
Gain on extinguishment of debt 951,868
Other income 40,000
Total other income (expenses), net 9,019 (97,474) 30,070 720,928
Net (loss) income $ (2,288,034) $ (591,021) $ (6,069,866) $ (911,998)
Net (loss) income per common share:        
Basic $ (0.07) $ (0.02) $ (0.18) $ (0.03)
Diluted $ (0.07) $ (0.02) $ (0.18) $ (0.03)
Weighted average number of common stock outstanding:        
Basic 34,039,906 31,065,688 33,445,006 27,829,820
Diluted 34,039,906 31,065,688 33,445,006 27,829,820